Top Markets
Coin of the day
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc. Common Stock

EIKN
Classificação em ações #12317
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established... Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.
Preço da ação
$11.03
Última sincronização: 2026-08-28
Valor de mercado
$597.15M
Variação (1 dia)
-4.25%
Variação (1 ano)
-
País
US
Negociar Eikon Therapeutics, Inc. Common Stock (EIKN)

Categoria

Histórico de preços das ações de Eikon Therapeutics, Inc. Common Stock (EIKN)
Preço de fecho mais alto: $10.87 em 2026-08-01

Preço de fecho mais baixo: $14.75 em 2026-02-01
Histórico de preços das ações da Eikon Therapeutics, Inc. Common Stock de 2026 a 2026
Desempenho anual do preço das ações
Ano Desempenho
Não há dados suficientes para as datas fornecidas.
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$542.09 38.63%
US
$1.03K 44.13%
NL
$120.75 -13.26%
AU
$138.18 473.58%
US
$759.27 7.20%
CH